chrisvoncsefalvay/vaers-outcomes huggingface dataset:
STARTING FEELING JITTERY AROUND 1045AM ON 9/23/22.   CAME DOWN TO PHARMACY DEPARTMENT TO STAFF AND FELT A LITTLE OFF.  AROUND 1115 AM, FELT MORE JITTERY AND AND HAD NOT EATEN, SO HAD SOME WATER AND 1/2 OF BAGEL. DIFFICULT TO GET DOWN, SWALLOW.  AROUND 1145, HAD ANOTHER PHARMACIST CHECK PULSE AND SHE NOTED IT BEING ERRATIC.  WENT DOWN TO EMPLOYEE HEALTH AND RN TOOK BP/HR.  BP=159/110 AND HR =155.  MAX HR UP INTO 170S.NURSE CALLED MEDICAL-PSYCH FLOOR FOR EKG, WHICH SHOWED ORIGINALLY ATRIAL FLUTTER, BUT THEN LISTED AS SVT PER RN/MD. IV STARTED AND MONITOR REMAINED ON UNTIL EMS ARRIVED AROUND 1PM TO TRANSPORT TO EMERGENCY DEPARTMENT. ON 9/23/22 CONVERTED BACK TO NORMAL SINUS RHYTHM(NSR) BY VASOVAGAL MANEUVER DOWN TO LOW 100s AROUND 3PM.  WITH IV MAG SULFATE 2GM, WAS ABLE TO COME BACK DOWN INTO THE 80S. AND DISCHARGED HOME AROUND 6PM SAME DAY WITH NO NEW MEDS.  ON 9/25/22 AROUND 2PM WHILE RESTING AT HOME, NOTICED ANOTHER EPISODE OF TACHYCARDIA, POUNDING IN THROAT AND CHEST. I  TRIED VASOVAGAL MANEUVER TO TRY AND CONVERT TO NSR. UNABLE TO DO, SO CALLED EMS AROUND 1445.  WHEN EMS ARRIVED,  EKG HOOKED UP AND NOTED TO BE IN SVT AGAIN.  TRANSFERRED TO ED AND WHILE IN ROUTE TO HOSPITAL, ADENOSINE 6MG IV GIVEN.  BRIEFLY CONVERTED TO NSR, BUT BACK UP INTO 150s FOR HR.  AFTER ARRIVAL AT ED,  HR STILL IN 150S WITH FLUCTUATIONS UP INTO 170s.   CARDIZEM 25MG IVP GIVEN AROUND 4PM AND FINALLY CONVERTED BACK TO NSR.  LABS-TSH, CBC, MG, PHOS, LIPID PANEL, HGBA1C, COVID SWAB FOR ADMIT-NEG, DRUG SCREEN -NEG.  ADMITTED TO HOSPITAL FROM ED AROUND 6PM FOR TELEMETRY MONITORING, SINCE 2ND EPISODE IN 48 HRS.  NO FURTHER EPISODES AND CARDIZEM CD 120MG QD STARTED ON 9/26/22  HR RUNNING STILL IN 90s. ON 9/26/22 ECHOCARDIOGRAM DONE  AROUND 2PM AND UNREMARKABLE.  DISCHARGED AROUND 7PM ON 9/26/22 WITH NEW RX FOR CARDIZEM CD 120MG QD.  F/U WITH PCP ON 10/11/22 AND CARDIOLOGY ON 10/28/22.
pt had tested positive for COVID ON 9/24/21, was started on ABX; brought to ED on 9/28/21 for altered mental status, obtundation; decreased LOC past 3 days, unresponsive to pain with spontaneous gurgling respirations, tachypnea; emergently intubated; COVID pneumonia and sepsis; treated with dexamethasone and remdesivir; eventually was extubated and placed on BIPAP; pt's condition worsened and she was placed on comfort care measures; she passed away in the hospital the next day
pt recv vax 15JAn97 & felt tired;22JAN97 pt liver function tests results were SGOT 280, SGPT 612;LDH 267;GGTP 24;& on 24JAN97 they were SGOT 266;SGPT 586;LDH 249;pt is undergoing a work-up;
Pharmacist did not mix the 1.3ml diluent with the vaccine before adminstering. Patient received 0.2ml of undiluted pediatric vaccine
raised bump (about the size of a quarter), redness (size about 3 inches by 1 inch), itchy
Patient's boyfriend called and stated that patient found out she was pregnant on 4/17/2023 and that she had received live virus vaccines on 4/14/2023.
4.5 hours after event while vigorously crying infant reportedly stopped breathing and became unresponsive x 30s.  Dad performed chest compressions and she returned to baseline prior to EMS arrival.  Transported to local hospital where diagnosed with BRUE (Brief Resolved Unexplaned Event) and Apnea.
2/18: Slightly sore arm. Awoke with headache. 1 hour later nausea began. Chills, temp which spiked at 102.4 degrees. Extreme fatigue. Slept 12 hours. 2/19: decreased headache, nausea, fever. Fatigue continued X 3 days.
pt recv vax 31JUL95 & on 4JUN97 pt exp a full-blown rash all over w/well over 200 lesions;
As soon as the injection was given IM, patient's arm felt numb. Now it is still tingling.  Itchy and swollen eyes, ears getting hot, itchiness on scalp and spreading, palpitations/increased heart rate, chest pain, slight straining when breathing.
Skin Rash. Patient received 1st dose of Varicella Vaccine SC on left arm & developed rash a few days later. Returned to see physician about 2 weeks after vaccination with mild headache, few pox-like lesions on upper arm & below left knee, pruritus; varicella IGM positive. Rash resolved without treatment.
Neuropathy; sore arm; This case was reported by a consumer via other manufacturer and described the occurrence of neuropathy in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included blood pressure high. Concomitant products included minerals nos + vitamins nos (Centrum) and losartan.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced neuropathy (serious criteria GSK medically significant) and pain in arm. The patient was treated with pregabalin (Lyrica). On an unknown date, the outcome of the neuropathy was not recovered/not resolved and the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the neuropathy and pain in arm to be related to Shingrix.  Additional information was provided as follows: The age at vaccination was not reported. The age group was captured as an adult as per vaccine indication. The patient got first shingles shot on unknown date and just had a sore arm for maybe a few days afterwards. The patient was receiving Lyrica for neuropathy. The reporter consented to follow up. For tolerance of 2nd dose refer case US2020AMR159352.; Sender's Comments:  US-Pfizer-2020307288: US-GLAXOSMITHKLINE-US2020AMR159352:same reporter
unusual high pitched cry for 9 1/2 hrs; extreme soreness @ site (unable to be touched); dec appetite;
injection site sore/injection site is tender; fatigue; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 14-Apr-2021 and was forwarded to Moderna on 14-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (injection site sore/injection site is tender) and FATIGUE (fatigue) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced VACCINATION SITE PAIN (injection site sore/injection site is tender) and FATIGUE (fatigue). At the time of the report, VACCINATION SITE PAIN (injection site sore/injection site is tender) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-076760 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-076760:Case deleted
Small bug-bite size red mark. Size of rash has grown to half dollar-size by 03/20/2010.
Tetanus vaccine area; local left shoulder/deltoid cellulitis. Admitted and treated with antibiotics. The discharge summary states syncopal episode.
Pt given IMOVAX rabies subcutaneously (SQ) instead of (IM) intramuscular. Per mom patient has no symptoms.
Patch of red skin on left arm slight lower than injection site, warm to the touch but not itchy or painful.
Approx at 10:55 c/o sob and feelings of something in her throat. A/0X3 no immediate distress of any observed. Benadryl 25 mg IV given by EMS. Pt recovered d/c to home per coworker on 12/16/05.
This spontaneous report was received from a licensed practical nurse and refers to a 13 year old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 31-AUG-2015 and on 09-MAY-2016, the patient was vaccinated with doses of GARDASIL 9 (lot # L007560, lot # L048237, expiration date, exact dose, route of administration and anatomical location were not reported), that had experienced a temperature excursion. No adverse reaction was reported. This is one of several reports received from the same reporter. Additional information has been requested.
Systemic: Flushed / Sweating-Mild, Systemic: Headache-Mild, Systemic: Seizure-Mild
Arm swelling, pain, erythema, "unable to make a fist." Symptoms partially subsided after 36 hours, but still erythema and slight swelling.
IMPROPER STORAGE OF VACCINE.  THERE WERE NO ADVERSE REACTIONS ROM THE PATIENT
Not feeling well, general malaise; Swelling on right Scapula; Uncomfortable feeling on right groin, felt blah; Left side clavicle area has large swollen glands; Left side glands are tender to touch; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Not feeling well, general malaise), TENDERNESS (Left side glands are tender to touch), BONE SWELLING (Swelling on right Scapula), FEELING ABNORMAL (Uncomfortable feeling on right groin, felt blah) and LYMPHADENOPATHY (Left side clavicle area has large swollen glands) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to metals (Allergic to nickel). Concomitant products included MISOPROSTOL, OMEPRAZOLE, VALPROATE SEMISODIUM (DEPAKOTE), MELATONIN, DIPHENHYDRAMINE and SUMATRIPTAN SUCCINATE (IMITREX DF) for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced TENDERNESS (Left side glands are tender to touch) and LYMPHADENOPATHY (Left side clavicle area has large swollen glands). On 17-Mar-2021, the patient experienced MALAISE (Not feeling well, general malaise), BONE SWELLING (Swelling on right Scapula) and FEELING ABNORMAL (Uncomfortable feeling on right groin, felt blah). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, MALAISE (Not feeling well, general malaise), TENDERNESS (Left side glands are tender to touch), BONE SWELLING (Swelling on right Scapula), FEELING ABNORMAL (Uncomfortable feeling on right groin, felt blah) and LYMPHADENOPATHY (Left side clavicle area has large swollen glands) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
can not keep anything down; this morning 15Apr21 she woke up with vomiting; fever 102F; body aches; vomiting which went away; This spontaneous case was reported by a consumer and describes the occurrence of UNEVALUABLE EVENT (can not keep anything down), PYREXIA (fever 102F), MYALGIA (body aches), VOMITING (vomiting which went away) and VOMITING (this morning 15Apr21 she woke up with vomiting) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 13-Apr-2021 at 8:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced PYREXIA (fever 102F), MYALGIA (body aches) and VOMITING (vomiting which went away). On 15-Apr-2021, the patient experienced UNEVALUABLE EVENT (can not keep anything down) and VOMITING (this morning 15Apr21 she woke up with vomiting). On 14-Apr-2021, PYREXIA (fever 102F), MYALGIA (body aches) and VOMITING (vomiting which went away) had resolved. At the time of the report, UNEVALUABLE EVENT (can not keep anything down) and VOMITING (this morning 15Apr21 she woke up with vomiting) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Apr-2021, Pyrexia: 102 (High) Patient reported fever 102F later that day and into 14 Apr21 which went away..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment drugs were reported.
I had a horrendous headache sore throat, general malaise, my chest hurt a lot. I used a home COVID-19 test; it came back positive. I had to use an online doctor as I was out of town to get the Paxlovid. I did start feeling better quicker than I thought I would. Although I got better, I remained short of breath, my lungs remained sensitive to smells for the next three and a half months. I remained exhausted. I did use my emergency asthma medication, Pulmicort to help me get through this time.
The pt woke the morning of 2/22/01 with local redness, swelling, not much discomfort at all. No limping and hasn't restricted her activities. No fever and no irritability.
No adverse event; administered with 0.25ml of the bivalent booster dose instead of the 0.5ml dose; This spontaneous case was reported by a nurse and describes the occurrence of UNDERDOSE (administered with 0.25ml of the bivalent booster dose instead of the 0.5ml dose) and NO ADVERSE EVENT (No adverse event) in a 69-year-old male patient who received mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7143C) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Sep-2022, the patient received dose of mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .25 milliliter. On 04-Sep-2022, the patient experienced UNDERDOSE (administered with 0.25ml of the bivalent booster dose instead of the 0.5ml dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, UNDERDOSE (administered with 0.25ml of the bivalent booster dose instead of the 0.5ml dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for UNDERDOSE (administered with 0.25ml of the bivalent booster dose instead of the 0.5ml dose).    Concomitant medication details were not reported by the reporter.  On 02-Mar-2021, patient received First dose of Moderna COVID-19 vaccine with batch number 002A21A.  On 30-Mar2021, patient received second dose  of Moderna COVID-19 vaccine with batch number 028A21A.  On 25-Oct-2021, patient received First booster  of Moderna COVID-19 vaccine dose with batch number 076C21A.  On 18-Apr-2022, patient received Second booster  of Moderna COVID-19 vaccine dose with batch number 001M21A.  The patient received the bivalent booster dose of the Moderna Covid-19 vaccine on 04-Sep-2022 and received 0.25ml instead of the 0.5ml dose. Vaccine provider called and informed patients that CDC recommended giving a full 0.5ml of the vaccine again instead of just 0.25.  Treatment details was not reported by the reporter.
After patient received Moderna COVID vaccine, waited 10 minutes, stood up and stated she felt short of breath and she felt her throat closing up.  administered EPI pen, called EMS, monitored patient until EMS arrived.
This spontaneous report as received from a pharmacist via a company representative refers to an unspecified number of unspecified children of unknown age and gender. The patients' concurrent conditions, medical history and concomitant medications were not reported. On an unknown dates, the patients were vaccinated with GARDASIL 9 (doses, frequencies, routes of administration and lot #s were not reported). On an unknown dates, the patients experienced neurological effects. The outcome of neurological effects was unknown. The causality assessment was not provided.
Influenza virus vaccine(FLUVIRIN) 2008-2009 formula expiration date 6/30/2009 given instead of 2009-2010 formula, vaccinated with influenza virus vaccine (FLUZONE) 2009-2010 formula after error discovered.
Slight fever, fatigue, breathlessness, body aches, headache started approximately 24 hours after injection and lasted for approximately 24 hours
Pericarditis, tachycardia, high blood pressure, visual issues, bed and wheelchair bound 5 months. Internal vibrations, neck tremors, blood pressure fluctuations, some kind of adrenal response episodes.
Patient received vaccination.  While he was sitting  for 15 minute post-observation he notified us that  he was feeling dizzy.  He also became pale and started sweating.  We had patient put his head between his knees, gave him some water, and a cool, moist towel.  After a few minutes patient felt much better and got his color back.  He never fainted or lost consciousness.
PT RECEIVED INJECTION AND WAS ASKED TO STAY FOR OBSERVATION AND WAS INSTRUCTED TO NOTIFY NURSE OF ANY CHANGES IN CONDITION.  AFTER APROX 5 MINS PT REPORTED SOME NAUSEA AND ASKED TO BE SHOWN TO NEAREST REST ROOM.  WALKED WITH PT TO LADIES ROOM, WAITED CLOSE BY AND CHECKED ON HER TWICE.  WAS IN REST ROOM FOR APROX 15 MINS. WHEN SHE EXITED ASSISTED HER BACK TO OBSERVATION AREA.  REPORTED DIARRHEA AND CONTINUED NAUSEA.  ASSESSED BLOOD PRESSURE.  85/51. CALLED FOR RRT.  TEAM ARRIVED AND ASSESSED PT.  PT REPORTED CONTINUED NAUSEA, WEAKNESS, CHILLS, AND APPEARED LETHARGIC.  PT REPORTED TO ED BY RRT.
Covid 19 PCR posiitive on 7/18/2021.  Narrative:
Starting later afternoon (5PM) 10/10/05 pt experienced moderate to severe pain and some swelling at injection site. Was unable to bring his arm across his chest until 10/13/05. Moving arm up and down was painful also. As of 10/16/05 symptoms were gone except for some pain near injection site. Still some minor pain at injection site. Patient received pneumo vaccine (left arm) and fluzone vaccine (right arm) on the same day Oct 10,2005. There was no problem w/the flu shot; only in the arm (left arm) with the pneumo shot. The patient now is recovered fully.
Systemic: Allergic: Difficulty Breathing-Medium, Additional Details: about 10 minutes after vaccine, patient reports has difficulty breathing, but stable. checking BP 113/65. pt can breath. Check with pt every 5 minutes, and stable breathing, BP is 99/59 after 10 minutes. Pt reports feeling better (without any intervention). Asked pt to wait for 30 minutes mark. Pt then said his throat is tight, but can still breath with no whezzing. Discuss with mom and want 911 call. No epipen is given.
Situation: ,  had an appointment for 1st dose Pfizer (Lot#: EW0187) today. Shortly after receiving the vaccine, the patient experienced 30-40 second syncopal episode and became dizzy. Father was able to assist patient. Pt did not eat this morning. Already had a box of juice prior to syncopal episode. Pt placed on a gurney and moved to room 6. Pt was pale and dizzy.  Background: patient has NKDA and demies PMH  Assessment: @0740 ? VS 114/75 (87) 72 97.0F 100%RA  @0743 ? Denies dizziness. Drank a box of juice and ate crackers. Pt stated that she is feeling normal.  @0748 ? sitting VS 109/60 (84) 71 16 100%RA                Standing VS 100/60 (77) 78 16 100%RA  @0750 ? Pt able to ambulate around the room. No SOB noted. NO s/sx of distress noted. Pt feels back to baseline and wants to go home. Father is confident in taking patient home.     Recommendation: Encourage increased fluid intake and plenty of rest today. Encourage to follow up with PMD if symptoms persist and to let vaccinators know about syncopal episode during next dose appt. Pt and father verbalized understanding. Pt ambulated with family towards private vehicle.
Admitted currently with pending pre-admit to continuing care. The patient is a 75 y.o. female who presents today   Patient has past history heart failure with preserved ejection fraction, hypertension, hyperlipidemia obstructive sleep apnea, diabetes mellitus type 2, paroxysmal atrial fibrillation on oral anticoagulation, CKD 3, chronic obstructive pulmonary disease.  Patient uses CPAP and home oxygen at night per spouse.  Echocardiogram 07/21/2021 LVEF 70%.  Limited study, small pericardial effusion.   Patient's breathing and coughing has been getting progressively worse of the last couple of days.  Patient denies fever, chills, chest pain.  Patient was brought in by EMS and found to have recurrent large right pleural effusion.  She had severe hypoxia w/oxygen sats reportedly in the 70's and arrive to ER on Bipap.  Patient reports compliance with her medication including her diuretics.  Patient's spouse manages patient's medication at home.  Patient uses salt and reports she is staying w/in her fluid restrictions but spouse disagrees.  Patient reports she has been too weak to stand on the scale and uses furniture to balance her when she ambulates.  Patient's cough is productive at times.  Patient denies pleuritic chest pain.  Patient is on Eliquis for PAFIB and she is also on plavix which her last doses were 1/18.  Patient denies hemoptysis, melena or hematochezia.  Patient reports stable or improved bilateral LE edema.  Patient denies dysphagia.  Patients last dose of lantus was evening 1/18.  Potassium 5.6, creatinine 1.44, bicarbonate 32, chloride 94, alkaline phosphatase 229, NT BNP 2459, glucose 362. Patient's pCO2 63 with a pH 7.37.  COVID 19 was detected.  Per chart review patient had a positive SARS-CoV-2 on 12/14 at another hospital.   Information is obtained from patient is limited historian and is on bipap. Spouse at bedside
Site: Bruising at Injection Site-Severe, Site: Swelling at Injection Site-Severe
Swollen lymph nodes in armpit of arm that received vaccine; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER8727), via an unspecified route of administration in the left arm on 20Mar2021 at 12:00 (at the age of 42-years-old), as a single dose for COVID-19 immunisation. Medical history included mitral valve prolapse with heart murmur. The patient did not take any concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not have allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On 21Mar2021 at 16:00, the patient experienced swollen lymph nodes in armpit of arm that received the vaccine. The patient underwent lab test and procedures which included PCR nasal swab in Sep2020 and tested negative. The patient did not receive any treatment for swollen lymph nodes. The event did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. The clinical outcome of the event swollen lymph nodes was recovering at the time of this report.   No follow-up attempts are possible. No further information is expected.
Pt recvd vax & w/in 5 mins p/vax was faint, clammy & had a racing pulse; pt was sent to ER;
Fatigue; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue) and MYALGIA (Body aches) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Psoriatic arthritis.    Concurrent medical conditions included Psoriatic arthritis.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) CF, UNK. On an unknown date, the patient experienced FATIGUE (Fatigue) and MYALGIA (Body aches). At the time of the report, FATIGUE (Fatigue) and MYALGIA (Body aches) outcome was unknown.            No concomitant product was reported. No treatment information was reported. It was unknown if patient was enrolled in a COVID-19 vaccine trial. The reporter's causality for the events with Humira was no reasonable possibility. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
patient complained of tinnitus post COVID vaccine, VS taken given water and monitored. Resolved after 30 minutes